SIBNNGMHealthcare·Medical Devices#47 in industry

SI-BONE, Inc.

Reports in 14d· 2026-05-11

-22.8% · 90d

$13.15

-0.37 (-2.74%)

After-Hours $13.15(+0.00)

News

(2)

April 2026

Apr 21, 20266 days agoARSHealthcare

SIBN reports $200 million revenue and positive EBITDA in 2025

SIBNSI-BONE, Inc.

# 📄 What This Document Is 🔎 This document is SI-BONE, Inc.'s Annual Report on Form 10-K. Think of this as the definitive year-end report card that the company provides to its investors and the public. It summarizes the company’s performance, its financial health, and its major risks over the fisca

Read summaryView on SEC EDGAR

Apr 21, 20266 days agoDEF 14AHealthcare

SIBN Proxy Details Annual Shareholder Vote on Directors and Auditors

SIBNSI-BONE, Inc.

# 📄 What This Document Is 📜 This document is a Proxy Statement (DEF 14A). Think of it as a mandatory "Who's Who and What's Happening" guide for the company's annual meeting. It is a legal filing that explains the specific business items that the company's stockholders are required to vote on and p

Read summaryView on SEC EDGAR

Key Data

Market Cap$581.8M

Open$13.46

Prev Close$13.52

Day Range$13.15 – $13.55

52W Range$12.15 – $21.89

Volume423,230

P/E (TTM)—

EPS$-0.44

Dividend Yield—

Beta0.77

Profit Margin-9.41%

Revenue Growth15.00%

Price Target$25.50(+93.9%)

Next Earnings2026-05-11(14d)

Analyst Ratings

Strong Buy8 analysts

Buy 8Hold 0Sell 0

About

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Healthcare · Medical Devices

376 employees

si-bone.com